News and Trends 2 Apr 2020
Swiss and German Team to Develop Inhaled mRNA Coronavirus Treatment
The Swiss antibody specialist Neurimmune and the German RNA biotech Ethris are collaborating to develop inhaled messenger RNA (mRNA) antibodies…
Neurimmune
- Latest Posts
More News! 4 Mar 2019
Swiss Biotech Raises €8.8M to Progress Regenerative Stroke Treatment
The Swiss company NovaGo has raised €8.8M (CHF 10M) in Series A funding to develop one of the first therapies…
More News! 9 Nov 2017
Swiss Biotech and Japanese Pharma Team Up to Tackle Neurodegenerative Disease
Neurimmune and Ono Pharmaceutical have partnered to develop an antibody drug against a still undisclosed neurodegenerative disease. Neurimmune has a new partner…
In Depth 3 Oct 2017
How Close Are We to Curing ALS? A Review of Biotech’s Efforts
May 5, 2017, saw the first FDA approval for an amyotrophic lateral sclerosis (ALS) drug in 20 years, when Edaravone/Radicava,…
ADVERTISEMENT
Best in Biotech 15 Mar 2017
What are the Best Countries to Recruit Biotech Talents in 2017?
Before the “who to recruit” phase, an important question is “where?” We ran through the top countries in which to look…
News and Trends 8 Dec 2016
Meet the Newest ALS Pioneer Company from Switzerland
AL-S Pharma was just born with the only purpose of developing a drug candidate for ALS, a rare condition for…
News and Trends 7 Jun 2016
Zurich is not all about Money – here are 9 Biotechs proving it!
The biggest city in Switzerland, Zurich, is one of Europe's top financial centers and home to the SIX Swiss Exchange…
